Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tumor stroma refers to the non-malignant supportive tissue surrounding and infiltrating tumors, including fibroblasts, immune cells, blood vessels, and extracellular matrix. Targeting the tumor stroma with alpha particle emission is an emerging strategy in cancer therapy to disrupt the tumor microenvironment and inhibit tumor growth and metastasis.
Delivery of cytotoxic α-particle emitters via specific ligands binding stromal components, leading to irreparable DNA damage and cell death.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Stroma.